Worldwide Pharmaceutical Drugs and Biologics Logistics Industry to 2030 - Players Include FedEx, UPS and DB Schenker Among Others

Dublin, IRELAND


Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drugs and Biologics Logistics Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics logistics market as it emerges from the COVID -19 shut down.

The global pharmaceutical drugs and biologics logistics market reached a value of nearly $90,300.0 million in 2020, having increased at a compound annual growth rate (CAGR) of 4.1% since 2015. The market is expected to reach $102,899.4 million by 2025, and $130,037.9 million by 2030.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 14+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the pharmaceutical drugs and biologics logistics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Pharmaceutical drugs and biologics logistics market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs and biologics logistics market, and compares it with other markets.

This report describes and evaluates the global pharmaceutical drugs and biologics logistics market. It covers three five-year periods, including, 2015 to 2020, termed the historic period, the forecast period, 2020-2025 and 2025-2030.

Growth in the historic period resulted from Increase in pharmaceutical sales, healthcare reforms, increase in outsourcing in the pharmaceutical industry, rapid growth in elderly population, strong economic growth in emerging markets, and rise in healthcare expenditure. Factors that negatively affected growth in the historic period were stringent regulations on drug distribution, poor infrastructure for cold chain logistics, regulatory challenges, and high costs of drug approval. Going forward, growing demand for and supply of temperature-sensitive products, distribution chain cost cutting measures, improving consistency and efficiency through logistics service providers, technological advances, new methods for drug discovery, large pool of undiagnosed population, and covid-19 pandemic will drive the growth. Factors that could hinder the growth of the pharmaceutical drugs and biologics logistics market in the future include underdeveloped logistics infrastructure, skill shortages, reduction in free trade, and development of oral biologics.

The global pharmaceuticals and biologics logistics market is fairly fragmented, with a large number of small players. The top ten competitors in the market made up to 20.38% of the total market in 2019. Major players in the market include FedEx, UPS Inc., Kuehne + Nagel, DB Schenker, and DSV Panalpina.

The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by type of service will arise in the non-cold chain logistics segment, which will gain $7,010.1 million of global annual sales by 2025. The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by mode of transport will arise in the land transportation segment, which will gain $7,161.7 million of global annual sales by 2025. The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by pharmaceutical type will arise in the pharmaceutical drugs segment, which will gain $8,597.0 million of global annual sales by 2025. The top opportunities in the pharmaceutical drugs and biologics logistics market segmented by therapeutic are will arise in the metabolic disorders drugs segment.

Market-trend-based strategies for the pharmaceutical drugs and biologics logistics market include acquiring new technologies and expertise, providing sea-based logistics services, focusing on patient-centric supply chains, using automated storage and retrieval systems, adopting advanced digital technologies, investing in reusable packaging, phase change materials, focusing on energy efficiency, and focusing on green supply chain management. Player-adopted strategies in the pharmaceutical drugs and biologics logistics market include expanding through strategic partnerships, and expanding through investing in building warehouses in different geographies.

To take advantage of the opportunities, the publisher recommends the pharmaceutical drugs and biologics logistics market companies to focus on acquiring companies, patient-centric supply chains, digitalization, investing in green supply chain management, expanding in emerging markets, provide competitively priced offerings, leverage social media, targeting distributors in emerging markets and collaboration with e-commerce companies.

Key Topics Covered

1. Pharmaceutical Drugs and Biologics Logistics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation by Geography
6.2. Segmentation by Type
6.3. Segmentation by Mode of Transport
6.4. Segmentation by Pharmaceutical Type
6.5. Segmentation by Therapeutic Area

7. Pharmaceutical Drugs and Biologics Logistics Market Characteristics
7.1. Market Definition
7.2. Segmentation by Type of Service
7.3. Segmentation by Mode of Transport
7.4. Segmentation by Pharmaceutical Type
7.5. Segmentation by Therapeutic Area

8. Pharmaceutical Drugs and Biologics Logistics Market Customer Information
8.1. Cargo-Airlines preparedness towards COVID-19 vaccine transportation
8.2. Effect of COVID-19 on transportation costs of biosimilars
8.3. GST Impacts on the Logistics Industry in India
8.4. Implementation of Mobile Technology in Logistics
8.5. Technology Adoption in Cold Chain Logistics
8.6. Growing Dependence on the Third-Party Logistics Providers

9. Pharmaceutical Drugs and Biologics Logistics PESTEL Analysis
9.1. Political
9.2. Economic
9.3. Social
9.4. Technological
9.5. Environmental
9.6. Legal

10. Pharmaceutical Drugs and Biologics Logistics Porter's Five Forces Analysis
10.1. Bargaining Power of Suppliers
10.2. Bargaining Power of Buyers
10.3. Threat of New Entrants
10.4. Threat of Substitutes
10.5. Competitive Rivalry

11. Pharmaceutical Drugs and Biologics Market Trends and Strategies
11.1. Increasing Consolidation in the Industry
11.2. Shift Towards Ocean Shipments
11.3. Automated Storage and Retrieval Systems
11.4. Patient-Centric Supply Chains
11.5. Blockchain and IoT in Pharmaceutical Logistics
11.6. Reusable Packaging for Shipping Pharmaceuticals
11.7. Phase Change Materials in Pharmaceutical Cold Chain
11.8. IATA Certification for Pharmaceutical Shipments
11.9. Green Supply Chain Management
11.10. Energy Efficiency

12. Impact of COVID-19 on the Pharmaceuticals and Biologics Logistics Market
12.1. Collaboration by Leading Players
12.2. Initiatives by Leading Players to Supply Covid-19 Vaccine and Other Pharmaceuticals
12.3. Government Intervention

13. Global Pharmaceutical Drugs and Biologics Logistics Market Size and Growth
13.1. Market Size
13.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
13.2.1. Drivers of the Market 2015 - 2020
13.2.2. Restraints on the Market 2015 - 2020
13.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.3.1. Drivers of the Market 2020 - 2025
13.3.2. Restraints on the Market 2020 - 2025

14. Pharmaceutical Drugs and Biologics Logistics Market, Regional Analysis
14.1. Global Pharmaceutical Drugs and Biologics Logistics Market, by Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.2. Global Pharmaceutical Drugs and Biologics Logistics Market, by Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Global Pharmaceutical Drugs and Biologics Logistics Market Segmentation
15.1. Global Pharmaceutical Drugs and Biologics Logistics Market, Segmentation by Type of Service of Service
15.2. Global Pharmaceutical Drugs and Biologics Logistics Market, Segmentation by Mode of Transport
15.3. Global Pharmaceutical Drugs and Biologics Logistics Market, Segmentation by Pharmaceutical Type
15.4. Global Pharmaceutical Drugs and Biologics Logistics Market, Segmentation by Therapeutic Area

16. Global Pharmaceutical Drugs and Biologics Logistics Market Comparison with Macro Economic Factors
16.1. Pharmaceutical Drugs and Biologics Logistics Market Size, Percentage of GDP, Global
16.2. Per Capita Average Pharmaceutical Drugs and Biologics Logistics Market Expenditure, Global

17. Asia-Pacific Pharmaceutical Drugs and Biologics Logistics Market

18. Western Europe Pharmaceutical Drugs and Biologics Logistics Market

19. Eastern Europe Pharmaceutical Drugs and Biologics Logistics Market

20. North America Pharmaceutical Drugs and Biologics Logistics Market

21. South America Pharmaceutical Drugs and Biologics Logistics Market

22. Middle East Pharmaceutical Drugs and Biologics Logistics Market

23. Africa Pharmaceutical Drugs and Biologics Logistics Market

24. Global Pharmaceutical Drugs and Biologics Logistics Market Competitive Landscape
24.1. Company Profiles
24.2. FedEx
24.2.1. Company Overview
24.2.2. Products and Services
24.2.3. Business Strategy
24.2.4. Financial Overview
24.3. UPS Inc.
24.3.1. Company Overview
24.3.2. Products and Services
24.3.3. Business Strategy
24.3.4. Financial Overview
24.4. Kuehne + Nagel
24.4.1. Company Overview
24.4.2. Products and Services
24.4.3. Business Strategy
24.4.4. Financial Overview
24.5. DB Schenker
24.5.1. Company Overview
24.5.2. Products and Services
24.5.3. Business Strategy
24.5.4. Financial Overview
24.6. DSV Panalpina
24.6.1. Company Overview
24.6.2. Products and Services
24.6.3. Financial overview

25. Key Mergers and Acquisitions in the Pharmaceutical Drugs and Biologics Logistics Market
25.1. Nippon Express Acquired MD Logistics
25.2. DSV Merged with Panalpina 25.3. Marken Acquired HRTL
25.4. Marken Acquired HETO
25.5. Marken Acquired Der Kurier
25.6. Lineage Logistics Acquired U.S. Growers Cold Storage's Temperature-Controlled Warehouses
25.7. Lineage Logistics Acquired Partner Logistics
25.8. Kuehne + Nagel Acquired Ferlito Pharma Logistics
25.9. UPS Acquired Marken
25.10. DHL Supply Chain Acquired Italian Group MIT Safetrans
25.11. VersaCold Logistics Services Acquired Coastal Pacific Xpress
25.12. CRYO International Acquired PDP Couriers

26. Global Pharmaceutical Drugs and Biologics Logistics Market Opportunities and Strategies
26.1. Global Pharmaceutical Drugs and Biologics Logistics Market in 2025 - Countries Offering most New Opportunities
26.2. Global Pharmaceutical Drugs and Biologics Logistics Market in 2025 - Segments Offering most New Opportunities
26.3. Global Pharmaceutical Drugs and Biologics Logistics Market in 2025 - Growth Strategies
26.3.1. Market Trend Based Strategies
26.3.2. Competitor Strategies

27. Pharmaceutical Drugs and Biologics Logistics Market, Conclusions and Recommendations
27.1. Conclusions
27.2. Recommendations
27.2.1. Product
27.2.2. Place
27.2.3. Price
27.2.4. Promotion
27.2.5. People

28. Appendix
28.1. Market Data Sources
28.2. Research Methodology
28.3. Currencies
28.4. Research Inquiries
28.5. About the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/cd3u7u

 

Contact Data